GPT and diabetes mellitus: Consistent with this, the ability to adoptively transfer diabetes to NODscid recipients by splenocytes from 28–32-day ALT-treated NODShiLt donors (9/13 diabetic; Figure 3B) was similar to that of control splenocytes (10/14 diabetic).